Top

Celebrating Biopharma: Of Triple Crowns And Unicorns

December 6, 2016

Via: Forbes
Category:

Everyone wants to invest in a unicorn, or so it seems. These are the investments that legendary track records are made of. But truth be told, unicorns don’t always lead to the biggest pots of gold at the end of the investment rainbow. David Coats at Correlation Ventures recently posted a great piece that frames up the topic nicely: “Unicorns are Overrated. Triple Crowns are Better.”

David came up with the latter term–triple crowns–to focus attention on deals that make great returns. Triple Crowns have three characteristics: realized investment multiples of at least 10x, realized IRRs of at least 100%, where VCs invested a meaningful amount of capital (>$1M).

Read More on Forbes